These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 11207304)

  • 1. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis.
    Poussin MA; Tüzün E; Goluszko E; Scott BG; Yang H; Franco JU; Christadoss P
    J Immunol; 2003 Apr; 170(8):4389-96. PubMed ID: 12682276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
    Zhang J; Bárdos T; Mikecz K; Finnegan A; Glant TT
    J Immunol; 2001 Apr; 166(8):4981-6. PubMed ID: 11290777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.
    Ostlie N; Milani M; Wang W; Okita D; Conti-Fine BM
    J Immunol; 2003 Jan; 170(1):604-12. PubMed ID: 12496449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
    Aruna BV; Ben-David H; Sela M; Mozes E
    Immunology; 2006 Jul; 118(3):413-24. PubMed ID: 16827902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.
    Stern BV; Boehm BO; Tary-Lehmann M
    J Immunol; 2002 Jun; 168(12):6099-105. PubMed ID: 12055220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF; Green WR
    J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.
    Maruta T; Oshima M; Mosier DR; Atassi MZ
    Autoimmunity; 2017 Aug; 50(5):293-305. PubMed ID: 28548588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
    Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
    J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naive CD4+ T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen.
    Ise W; Totsuka M; Sogawa Y; Ametani A; Hachimura S; Sato T; Kumagai Y; Habu S; Kaminogawa S
    J Immunol; 2002 Apr; 168(7):3242-50. PubMed ID: 11907078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner.
    Janssens W; Carlier V; Wu B; VanderElst L; Jacquemin MG; Saint-Remy JM
    J Immunol; 2003 Nov; 171(9):4604-12. PubMed ID: 14568934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells.
    Pál E; Tabira T; Kawano T; Taniguchi M; Miyake S; Yamamura T
    J Immunol; 2001 Jan; 166(1):662-8. PubMed ID: 11123351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.
    Tüzün E; Scott BG; Goluszko E; Higgs S; Christadoss P
    J Immunol; 2003 Oct; 171(7):3847-54. PubMed ID: 14500686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
    Wang W; Ostlie NS; Conti-Fine BM; Milani M
    J Immunol; 2004 Jan; 172(1):97-103. PubMed ID: 14688314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis by neglect of CD4+ Th cells in granulomas: a novel effector mechanism involved in the control of egg-induced immunopathology in murine schistosomiasis.
    Rutitzky LI; Mirkin GA; Stadecker MJ
    J Immunol; 2003 Aug; 171(4):1859-67. PubMed ID: 12902487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
    J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production.
    Hamad AR; Mohamood AS; Trujillo CJ; Huang CT; Yuan E; Schneck JP
    J Immunol; 2003 Sep; 171(5):2421-6. PubMed ID: 12928389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.